← Home · All topics

Trial

26 GoKawiil briefs on this topic

FDA Approves Daraxonrasib for Pancreatic Cancer After Trial Shows Doubled Survival

The FDA has cleared daraxonrasib, a new drug for pancreatic cancer, after a large clinical trial found patients on the treatment survived roughly twice as long as those receiving standard chemotherapy. The approval gives doctors a new option for a disease long known for poor treatment outcomes.

gizmodo.com · 2026-08-26

Small trial finds peppermint oil supplement lowers systolic blood pressure

A 20-day randomized, placebo-controlled trial of 40 people with pre- and stage 1 hypertension found that those taking 100 μL of peppermint oil daily saw systolic blood pressure drop from 130.05 to 121.97 mmHg, compared to no meaningful change in the placebo group. The adjusted difference between groups was 8.48 mmHg, with high compliance and only one adverse event reported.

journals.plos.org · 2026-08-24

‹ prev 1 2 3